×
Navidea Biopharmaceuticals EBITDA 2010-2023 | NAVB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Navidea Biopharmaceuticals ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
View More
Navidea Biopharmaceuticals EBITDA 2010-2023 | NAVB
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Navidea Biopharmaceuticals ebitda from 2010 to 2023. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$180.6B
Intuitive Surgical (ISRG)
$177.8B
Edwards Lifesciences (EW)
$46.9B
IDEXX Laboratories (IDXX)
$45.5B
Alcon (ALC)
$45.3B
DexCom (DXCM)
$34.9B
IQVIA Holdings (IQV)
$33.9B
Mettler-Toledo (MTD)
$26.3B
STERIS (STE)
$22.7B
Waters (WAT)
$18B
SONOVA HOLDING (SONVY)
$17.5B
Hologic (HOLX)
$14.8B
Sysmex ADR (SSMXY)
$10.7B
Penumbra (PEN)
$9B
Masimo (MASI)
$8.9B
Globus Medical (GMED)
$7.4B
Glaukos (GKOS)
$5.4B
Teleflex (TFX)
$5.2B
Integer Holdings (ITGR)
$3.8B
TransMedics (TMDX)
$3.7B
PROCEPT BioRobotics (PRCT)
$3.1B
LivaNova (LIVN)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
Elekta AB (EKTAY)
$2B
Veracyte (VCYT)
$2B
Alphatec Holdings (ATEC)
$1.6B
Artivion (AORT)
$1.3B
Paragon 28 (FNA)
$1.1B
OPKO Health (OPK)
$1.1B
Tandem Diabetes Care (TNDM)
$1.1B